1. Home
  2. HURN vs OGN Comparison

HURN vs OGN Comparison

Compare HURN & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HURN
  • OGN
  • Stock Information
  • Founded
  • HURN 2002
  • OGN 1923
  • Country
  • HURN United States
  • OGN United States
  • Employees
  • HURN N/A
  • OGN N/A
  • Industry
  • HURN Professional Services
  • OGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • HURN Consumer Discretionary
  • OGN Health Care
  • Exchange
  • HURN Nasdaq
  • OGN Nasdaq
  • Market Cap
  • HURN 2.6B
  • OGN 2.7B
  • IPO Year
  • HURN 2004
  • OGN N/A
  • Fundamental
  • Price
  • HURN $149.94
  • OGN $10.57
  • Analyst Decision
  • HURN Strong Buy
  • OGN Buy
  • Analyst Count
  • HURN 4
  • OGN 3
  • Target Price
  • HURN $171.50
  • OGN $17.33
  • AVG Volume (30 Days)
  • HURN 129.1K
  • OGN 3.6M
  • Earning Date
  • HURN 10-28-2025
  • OGN 10-30-2025
  • Dividend Yield
  • HURN N/A
  • OGN 0.75%
  • EPS Growth
  • HURN 37.96
  • OGN N/A
  • EPS
  • HURN 5.74
  • OGN 2.69
  • Revenue
  • HURN $1,556,665,000.00
  • OGN $6,281,000,000.00
  • Revenue This Year
  • HURN $13.32
  • OGN N/A
  • Revenue Next Year
  • HURN $8.31
  • OGN $0.79
  • P/E Ratio
  • HURN $26.20
  • OGN $3.95
  • Revenue Growth
  • HURN 9.24
  • OGN N/A
  • 52 Week Low
  • HURN $102.95
  • OGN $8.01
  • 52 Week High
  • HURN $155.00
  • OGN $19.05
  • Technical
  • Relative Strength Index (RSI)
  • HURN 68.60
  • OGN 54.85
  • Support Level
  • HURN $143.99
  • OGN $10.05
  • Resistance Level
  • HURN $153.19
  • OGN $11.29
  • Average True Range (ATR)
  • HURN 3.02
  • OGN 0.35
  • MACD
  • HURN 0.41
  • OGN 0.00
  • Stochastic Oscillator
  • HURN 73.73
  • OGN 44.76

About HURN Huron Consulting Group Inc.

Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: